Evidence map›Paper›PMID 33937270›Full record

ArticleFrontiers in cell and developmental biology2021

5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neurotransmitters.

Rafael Franco, Rafael Rivas-Santisteban, Jaume Lillo, Jordi Camps, Gemma Navarro, Irene Reyes-Resina

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rafael FrancoDepartment Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Barcelona, Spain.
Rafael Rivas-SantistebanDepartment Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Barcelona, Spain.
Jaume LilloDepartment Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Barcelona, Spain.
Jordi CampsDepartment Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Barcelona, Spain.
Gemma NavarroCentro de Investigación en Red, Enfermedades Neurodegenerativas (CIberNed), Instituto de Salud Carlos III, Madrid, Spain.
Irene Reyes-ResinaDepartment Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-hydroxytryptamine (5-HT) is derived from the essential amino acid L-tryptophan. Although the compound has been studied extensively for its neuronal handling and synaptic actions, serotonin 5-HT receptors can be found extra-synaptically and not only in neurons but in many types of mammalian cells, inside and outside the central nervous system (CNS). In sharp contrast, glutamate (Glu) and ATP are better known as metabolism-related molecules, but they also are neurotransmitters, and their receptors are expressed on almost any type of cell inside and outside the nervous system. Whereas 5-hydroxytryptamine and Glu are key regulators of the immune system, ATP actions are more general. 5-hydroxytryptamine, ATP and Glu act through both G protein-coupled receptors (GPCRs), and ionotropic receptors, i.e., ligand gated ion channels. These are the three examples of neurotransmitters whose actions as holistic regulatory molecules are briefly put into perspective here.

Indexed as

adenosine receptorsCOVID-19heartimmune systeminflammatory bowel diseaseP2 receptorspurinergic signalingserotonin

Identifiers

PMID33937270
PMCPMC8083958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.